|会社名||MidWestOne Financial Group Inc. （ミッドウェストワン・ファイナンシャル・グル―プ）|
|概要||事業概要 ミットウェストワン・ファイナンシャル・グループ（MidWestOne Financial Group Inc）は銀行持株・金融持株会社である。同社は銀行子会社MidWestOne Bank、Central Bankとアイオワ州中部と中東部に位置する3つの代理店を運営するMidWestOne Insurance Services Incを通じて運営する。同社は支社が所在する地域にフルサービスのリテールバンキングを提供し、信託および投資管理サービスも提供する。同行は小切手およびその他のデポジット預金口座、引き落とし可能（NOW）口座、貯蓄口座、マネーマーケット口座、預金証書、個別退職勘定およびその他の定期預金を含む預金商品を提供する。同行は商業用および工業用、農業用、不動産用のモーゲージおよび消費者ローンを提供する。 ミッドウェストワン・ファイナンシャル・グル―プは、米国の銀行持株会社。アイオワ州において個人、企業、政府、機関向けに銀行業務を提供。貯蓄、定期預金を扱うほか、商業ロ―ン、不動産ロ―ン、農業ロ―ン、消費者ロ―ンを提供する。また他の管理サ―ビスを提供するとともに、土地建物、個人信託、後見人、年金・利益分配口座などの管理を行う。 MidWestOne Financial Group, Inc. is a financial holding company headquartered in Iowa City, Iowa. MidWestOne is the parent company of MidWestOne Bank, which operates banking offices in Iowa, Minnesota, Wisconsin, Florida, and Colorado. MidWestOne provides electronic delivery of financial services through its website, MidWestOne.bank.|
|本社所在地||102 South Clinton Street Iowa City IA 52240 USA|
|代表者氏名||Kevin W. Monson ケヴィン・W・モンソン|
|代表者役職名||Independent Chairman of the Board|
|市場名||NASDAQ National Market System|
|決算概要||決算概要 BRIEF: For the six months ended 30 June 2018 MidWestOne Financial Group Inc. interest income increased 8% to $63M. Net interest income after loan loss provision increased 2% to $49.8M. Net income increased 14% to $15.9M. Net interest income after loan loss provision reflects Interest and Fees on Loans increase of 8% to $54.1M Taxable securities increase of 10% to $5.8M.|
MidWestOne Financial Group, Inc. (MOFG): Hedge Fund Sentiment Unchanged 2021/06/30 13:06:15 Insider Monkey
MidWestOne Financial Group, Inc. (NASDAQ:MOFG) COO Len D. Devaisher Acquires 1,485 Shares 2021/05/12 10:58:41 Transcript Daily
MidWestOne Financial Group, Inc. (NASDAQ:MOFG) COO Len D. Devaisher bought 1,485 shares of the stock in a transaction dated Monday, May 10th. The stock was purchased at an average price of $31.25 per share, with a total value of $46,406.25. Following the purchase, the chief operating officer now owns 8,811 shares in the company, valued 
MidWestOne Financial Group, Inc. (NASDAQ:MOFG) COO Len D. Devaisher Buys 1,485 Shares 2021/05/11 15:42:41 Dakota Financial News
MidWestOne Financial Group, Inc. (NASDAQ:MOFG) COO Len D. Devaisher bought 1,485 shares of the businesss stock in a transaction that occurred on Monday, May 10th. The shares were acquired at an average cost of $31.25 per share, with a total value of $46,406.25. Following the completion of the purchase, the chief operating officer now owns 
MidWestOne Financial Group Inc. Shares Close in on 52-Week High - Market Mover 2021/03/12 22:30:00 Kwhen Finance
MidWestOne Financial Group Inc. shares closed today at 0.2% below its 52 week high of $32.99, giving the company a market cap of $526M. The stock is currently up 35.5% year-to-date, up 52.9% over the past 12 months, and up 40.8% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%. Trading Activity Trading volume this week was 7.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 39.6% The company's stock price performance over the past 12 months beats the peer average by 15.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 273.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to firstname.lastname@example.org. © 2020 Kwhen Inc.
The Toronto-Dominion Bank 2021 Q2 - Results - Earnings Call Presentation 2021/05/27 15:41:46 Seeking Alpha
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs 2021/05/27 12:23:08 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB ) Nuvation Bio Inc. (NYSE: NUVB ) PDS Biotechnology Corporation (NASDAQ: PDSB ) Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS ) PLx Pharma Inc. (NASDAQ: PLXP ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 26) Assembly Biosciences, Inc. (NASDAQ: ASMB ) Axcella Health Inc. (NASDAQ: AXLA ) Black Diamond Therapeutics, Inc. (NASDAQ: BDTX ) Bolt Biotherapeutics, Inc. (NASDAQ: BOLT ) Coherus BioSciences, Inc. (NASDAQ: CHRS ) Evofem Biosciences, Inc. (NASDAQ: EVFM ) Impel NeuroPharma, Inc. (NASDAQ: IMPL ) IMV Inc. (NASDAQ: IMV ) Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT ) Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA ) Larimar Therapeutics, Inc. (NASDAQ: LRMR ) ( reacted to a clinical hold imposed on Phase 1 study of CTI-1601 in Friedreich ataxia) Spruce Biosciences, Inc. (NASDAQ: SPRB ) Travere Therapeutics, Inc. (NASDAQ: TVTX ) (flagged a delay in regulatory filing for drug to treat kidney scarring) Viking Therapeutics, Inc. (NASDAQ: VKTX ) Stocks In Focus Vir-GlaxoSmithKline's Antibody Treatment Approved For Mild-To-Moderate COVID-19 GlaxoSmithKline plc (NYSE: GSK ) and Vir Biotechnology, Inc. (NASDAQ: VIR ) said the FDA granted an emergency use authorization for sotrovimab, an investigational single-dose monoclonal antibody, for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients12 years of age and older weighing at least 40 kg who have tested positive for SARS-CoV-2 and who are at high risk for progression to severe COVID-19, including hospitalization or death.
Auxly inks agreement with Myconic Capital to sell KGK Science for $16.5M 2021/05/27 11:27:53 Seeking Alpha
Medtronic raises dividends and issues FY22 guidance as Q4 results beat expectations 2021/05/27 11:26:29 Seeking Alpha
Iowa City-based MidwestOne reports net loss for third quarter after goodwill write-down 2020/10/30 20:00:35 The Gazette Iowa
Iowa City-based MidWestOne Financial Group, the holding company for MidWestOne Bank, reported a net loss of $19.8 million for the third quarter ending Sept. 30 after having to make a goodwill write-down. Without that write-down, the bank would’ve reported an $11.7 million profit. The goodwill is largely a result of MidwestOne’s acquisitions. Banks usually purchase other banks at a price higher than its net worth. The difference between the selling price and the acquired bank’s net worth is goodwill. “We feel like we had a pretty good quarter,” said Charles Funk, the bank’s CEO. The goodwill write-down, totaling $31.5 million, happens when the market value of the bank — the value dictated by the stock price — is more than the bank’s net worth. A significant loss in MidwestOne’s stock price during the third quarter caused the write-down. It went from 21.24 per share midway through the quarter to 16.80 per share a few days before the quarter ended. “Our share price, like most bank stocks, has been hit pretty hard post-pandemic,” MidWestOne Chief Financial Officer Barry Ray said. “Most banks, including ours, haven’t really enjoyed the recovery that the broader market has. …
MidWestOne Financial Group (NASDAQ:MOFG) Stock Rating Upgraded by TheStreet 2020/10/24 11:04:42 Zolmax News
MidWestOne Financial Group (NASDAQ:MOFG) was upgraded by equities researchers at TheStreet from a “c” rating to a “b-” rating in a research note issued on Thursday, TheStreetRatingsTable reports. Other analysts have also recently issued research reports about the company. ValuEngine upgraded MidWestOne Financial Group from a “sell” rating to a “hold” rating in a research […]
MidWestOne (MOFG) Earnings Expected to Grow: What to Know Ahead of Q1 Release 2020/04/16 16:31:58 Zacks Investment Research
MidWestOne (MOFG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MidWestOne (MOFG) Q3 Earnings and Revenues Surpass Estimates 2019/10/24 23:25:06 Zacks Investment Research
MidWestOne (MOFG) delivered earnings and revenue surprises of 6.02% and 6.35%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Are You Looking for a High-Growth Dividend Stock? MidWestOne (MOFG) Could Be a Great Choice 2019/10/21 13:15:07 Zacks Investment Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MidWestOne (MOFG) have what it takes? Let's find out.